Ingredient

Alogliptin Benzoate

Alogliptin benzoate is a blood sugar control ingredient used to treat type 2 diabetes.

See medicines used for Chronic Conditions
All medicines
15
Single ingredient
3
Combination
12
Prescription medication
15

MFDS ingredient code M257113

What does it do?

Alogliptin benzoate belongs to the DPP-4 inhibitor class of antidiabetic medications. This ingredient is used to promote insulin secretion and inhibit blood sugar spikes in order to lower blood sugar levels.

Alogliptin benzoate inhibits the DPP-4 enzyme in the body, preventing the breakdown of incretin hormones. This leads to increased insulin secretion and effective blood sugar control.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Alogliptin benzoate has higher selectivity compared to other DPP-4 inhibitors, resulting in a relatively lower risk of side effects. Additionally, it can be used both as a monotherapy or in combination with other antidiabetic medications.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

15 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.